v3.25.2
Reporting Entity (Details)
6 Months Ended
Nov. 21, 2023
Jun. 30, 2025
USD ($)
Jun. 30, 2025
CHF (SFr)
Jun. 30, 2025
EUR (€)
Jun. 30, 2025
AUD ($)
Altamira Therapeutics AG [Member]          
Reporting Entity [Line Items]          
Ownership percentage in subsidiary   100.00%      
Share capital of subsidiary     SFr 2,500,000    
Otolanum AG [Member]          
Reporting Entity [Line Items]          
Ownership percentage in subsidiary   100.00%      
Share capital of subsidiary     100,000    
Altamira Therapeutics, Inc. [Member]          
Reporting Entity [Line Items]          
Ownership percentage in subsidiary   100.00%      
Share capital of subsidiary | $   $ 100      
Auris Medical AG [Member]          
Reporting Entity [Line Items]          
Ownership percentage in subsidiary 51.00% 49.00%      
Share capital of subsidiary     SFr 3,000,000    
Auris Medical Ltd. [Member]          
Reporting Entity [Line Items]          
Ownership percentage in subsidiary   49.00%      
Share capital of subsidiary | €       € 100  
Auris Medial Pty Ltd [Member]          
Reporting Entity [Line Items]          
Ownership percentage in subsidiary 100.00% 49.00%      
Share capital of subsidiary | $         $ 100
Investment equity percentage 49.00%        
Spinning off percentage   49.00%